GLP-1R and Diabetes
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Video zu Diabetes Typ 2: Wie wirken GLP-1-Analoga?
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism - ScienceDirect
2 Medikamentöse Therapie des Glukosestoffwechsels — Leitlinien.de
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors
Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes | Pharmacological Reviews
GLP-1: Actions on Beta-cell Mass and Function
Contemporary Updates on the Physiology of Glucagon like Peptide-1 and Its Agonist to Treat Type 2 Diabetes Mellitus | SpringerLink
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
GLP-1 gene delivery for the treatment of type 2 diabetes: Molecular Therapy
Therapeutic potential of GLP-1 in type 2 diabetes mellitus | Download Table
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial - The Lancet
Combination SGLT2, GLP-1 therapy lowers risk for adverse CV outcomes in type 2 diabetes
Oral GLP1 Gene Delivery by an Antibody-Guided Nanomaterial to Treat Type 2 Diabetes Mellitus | ACS Applied Materials & Interfaces
GLP-1 receptor agonist for type 2 diabetes - Clinical Advisor
Treatment of type 2 diabetes with incretin-based therapies - The Lancet
Glucagon Like Peptide 1 (GLP-1) Agonist Drugs for Type 2 Diabetes | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
Kardiovaskuläre oder renale Vorerkrankungen bei Patienten mit Typ-2-Diabetes: Der GLP-1-Rezeptoragonist Efpeglenatid schützt Herz, Blutgefäße und die...
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
Biology | Free Full-Text | Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Glucagon-like peptide-1 - Wikipedia
GLP-1 Agonist Effects on Glucagon Suppression
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes: Molecular Therapy
